| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A biochemical definition of cure after brachytherapy for prostate cancer
|
Crook, Juanita M.
|
|
|
149 |
C |
p. 64-69
|
artikel
|
| 2 |
Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT)
|
Alayed, Yasir
|
|
|
149 |
C |
p. 8-13
|
artikel
|
| 3 |
Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma
|
Martin, Daniel
|
|
|
149 |
C |
p. 168-173
|
artikel
|
| 4 |
Advocacy to provide good quality oncology services during the COVID-19 pandemic – Actions at 3-levels
|
Lee, Anne W.M.
|
|
|
149 |
C |
p. 25-29
|
artikel
|
| 5 |
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC
|
Göttgens, Eva-Leonne
|
|
|
149 |
C |
p. 1-7
|
artikel
|
| 6 |
BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
|
Hsu, Yin-Chou
|
|
|
149 |
C |
p. 249-258
|
artikel
|
| 7 |
Bracing for impact with new 4R’s in the COVID-19 pandemic – A provincial thoracic radiation oncology consensus
|
Rathod, Shrinivas
|
|
|
149 |
C |
p. 124-127
|
artikel
|
| 8 |
Cancer oligometastases heterogeneity: Standardizing nomenclature. In regard to defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|
Boon, Ian S.
|
|
|
149 |
C |
p. 247-248
|
artikel
|
| 9 |
Cancer patients in Covid-19 era: Swimming against the tide
|
Gregucci, Fabiana
|
|
|
149 |
C |
p. 109-110
|
artikel
|
| 10 |
Can we prevent COVID-19 from causing victims among uninfected cancer patients?
|
Ramella, Sara
|
|
|
149 |
C |
p. 63
|
artikel
|
| 11 |
Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
|
Beukema, Jannet C.
|
|
|
149 |
C |
p. 222-227
|
artikel
|
| 12 |
Challenges in conducting large randomised control trials of palliative radiotherapy in head and neck cancer
|
Iqbal, Muhammad Shahid
|
|
|
149 |
C |
p. 246
|
artikel
|
| 13 |
Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
|
Offin, Michael
|
|
|
149 |
C |
p. 205-211
|
artikel
|
| 14 |
Contents
|
|
|
|
149 |
C |
p. v-vii
|
artikel
|
| 15 |
COVID-19 outbreak and cancer patient management: Viewpoint from radio-oncologists
|
Zhen, Hongnan
|
|
|
149 |
C |
p. 44-45
|
artikel
|
| 16 |
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
|
Jereczek-Fossa, Barbara Alicja
|
|
|
149 |
C |
p. 89-93
|
artikel
|
| 17 |
Covid-19 outbreak in a major radiation oncology department; which lessons should be taken?
|
Gemici, Cengiz
|
|
|
149 |
C |
p. 107-108
|
artikel
|
| 18 |
COVID-19, radiotherapy and cancer
|
Sriwijitalai, Won
|
|
|
149 |
C |
p. 48
|
artikel
|
| 19 |
Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial
|
Herst, Patries M
|
|
|
149 |
C |
p. 117-123
|
artikel
|
| 20 |
Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer
|
Nakamura, Masaki
|
|
|
149 |
C |
p. 14-17
|
artikel
|
| 21 |
Dose prediction using a deep neural network for accelerated planning of rectal cancer radiotherapy
|
Song, Ying
|
|
|
149 |
C |
p. 111-116
|
artikel
|
| 22 |
Dose–volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis
|
|
|
|
149 |
C |
p. 142-149
|
artikel
|
| 23 |
Editorial Board
|
|
|
|
149 |
C |
p. ii
|
artikel
|
| 24 |
Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy
|
Mason, Josh
|
|
|
149 |
C |
p. 38-43
|
artikel
|
| 25 |
Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods
|
Esposito, Marco
|
|
|
149 |
C |
p. 158-167
|
artikel
|
| 26 |
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer
|
Fastner, Gerd
|
|
|
149 |
C |
p. 150-157
|
artikel
|
| 27 |
Feasibility of cone beam CT-guided library of plans strategy in pre-operative gastric cancer radiotherapy
|
Bleeker, Margot
|
|
|
149 |
C |
p. 49-54
|
artikel
|
| 28 |
Feasibility of 3D tracking and adaptation of VMAT based on VMAT-CT
|
Zhao, Xiaodong
|
|
|
149 |
C |
p. 18-24
|
artikel
|
| 29 |
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy
|
Cecchin, Erika
|
|
|
149 |
C |
p. 30-37
|
artikel
|
| 30 |
Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching
|
Grimwood, Alexander
|
|
|
149 |
C |
p. 134-141
|
artikel
|
| 31 |
Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy
|
Zschaeck, Sebastian
|
|
|
149 |
C |
p. 189-196
|
artikel
|
| 32 |
Nationwide survey of COVID-19 prevention measures in Japanese radiotherapy departments via online questionnaire for radiation oncologists
|
Tamari, Keisuke
|
|
|
149 |
C |
p. 219-221
|
artikel
|
| 33 |
Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation
|
Garda, Allison E.
|
|
|
149 |
C |
p. 128-133
|
artikel
|
| 34 |
Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation
|
Bolsi, Alessandra
|
|
|
149 |
C |
p. 197-204
|
artikel
|
| 35 |
Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic – A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group
|
Vavassori, Andrea
|
|
|
149 |
C |
p. 73-77
|
artikel
|
| 36 |
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration
|
Broggi, Sara
|
|
|
149 |
C |
p. 174-180
|
artikel
|
| 37 |
Prevention and control measure to avoid cross infection during radiotherapy in coronavirus disease 2019 (COVID-19) epidemic in Wuhan, China
|
Zhang, Li
|
|
|
149 |
C |
p. 104-106
|
artikel
|
| 38 |
Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy
|
Lan, Kaiqi
|
|
|
149 |
C |
p. 228-235
|
artikel
|
| 39 |
Radiotherapy and COVID-19: Practical recommendations from iran
|
Aghili, Mahdi
|
|
|
149 |
C |
p. 70-71
|
artikel
|
| 40 |
Radiotherapy for COVID-19: Primum non nocere
|
Boon, Ian S.
|
|
|
149 |
C |
p. 236-237
|
artikel
|
| 41 |
Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma
|
Al-Mamgani, Abrahim
|
|
|
149 |
C |
p. 181-188
|
artikel
|
| 42 |
Reduced increase of calcium scores using breath-hold in left-sided whole breast irradiation
|
Mast, M.E.
|
|
|
149 |
C |
p. 78-83
|
artikel
|
| 43 |
Response Letter: Radiation therapy for COVID-19 pneumopathy
|
Kirsch, David G.
|
|
|
149 |
C |
p. 238-239
|
artikel
|
| 44 |
Response to: RILI model and the Covid-19 pneumonia: The radiation oncologist point of view
|
Kirkby, Charles
|
|
|
149 |
C |
p. 72
|
artikel
|
| 45 |
The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques
|
Paganetti, Harald
|
|
|
149 |
C |
p. 212-218
|
artikel
|
| 46 |
The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review
|
Oldenburger, E.
|
|
|
149 |
C |
p. 94-103
|
artikel
|
| 47 |
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
|
Putora, P.M.
|
|
|
149 |
C |
p. 84-88
|
artikel
|
| 48 |
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life
|
Sanmamed, Noelia
|
|
|
149 |
C |
p. 240-245
|
artikel
|
| 49 |
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?
|
Jin, Jian-Yue
|
|
|
149 |
C |
p. 55-62
|
artikel
|
| 50 |
What is our threshold: Departmental planning for radiation oncology’s future in the time of COVID-19
|
Chandra, Ravi A.
|
|
|
149 |
C |
p. 46-47
|
artikel
|
Tijdschrift beschrijving